erythrosine has been researched along with Parkinson Disease in 11 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effects of paeonol on neuron cell model of Parkinson disease (PD)." | 7.81 | [Neuroprotective effects of paeonol in a cell model of Parkinson disease]. ( Geng, ZM; Hu, ZW; Wang, H; Wang, SY; Zhao, B, 2015) |
| "To investigate the effects of paeonol on neuron cell model of Parkinson disease (PD)." | 3.81 | [Neuroprotective effects of paeonol in a cell model of Parkinson disease]. ( Geng, ZM; Hu, ZW; Wang, H; Wang, SY; Zhao, B, 2015) |
| "Rotenone (1 μg) was unilaterally injected into the median forebrain bundle to induce the degeneration of the nigrostriatal pathway." | 1.51 | Nicotine-Induced Neuroprotection in Rotenone In Vivo and In Vitro Models of Parkinson's Disease: Evidences for the Involvement of the Labile Iron Pool Level as the Underlying Mechanism. ( Abin-Carriquiry, JA; Costa, G; Dajas, F; Ferreira, M; Mouhape, C; Prunell, G, 2019) |
| "Prion diseases are associated with the misfolding of the host-encoded cellular prion protein (PrP(C)) into a disease associated form (PrP(Sc))." | 1.35 | Conformational detection of prion protein with biarsenical labeling and FlAsH fluorescence. ( Cappai, R; Coleman, BM; Han, S; Hatters, DM; Hill, AF; Nisbet, RM, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Hannestad, JK | 1 |
| Rocha, S | 1 |
| Agnarsson, B | 1 |
| Zhdanov, VP | 1 |
| Wittung-Stafshede, P | 1 |
| Höök, F | 1 |
| Flavin, WP | 1 |
| Bousset, L | 1 |
| Green, ZC | 1 |
| Chu, Y | 1 |
| Skarpathiotis, S | 1 |
| Chaney, MJ | 1 |
| Kordower, JH | 1 |
| Melki, R | 1 |
| Campbell, EM | 1 |
| Mouhape, C | 1 |
| Costa, G | 1 |
| Ferreira, M | 1 |
| Abin-Carriquiry, JA | 1 |
| Dajas, F | 1 |
| Prunell, G | 1 |
| van Diggelen, F | 1 |
| Hrle, D | 1 |
| Apetri, M | 1 |
| Christiansen, G | 1 |
| Rammes, G | 1 |
| Tepper, A | 1 |
| Otzen, DE | 1 |
| Wang, H | 1 |
| Geng, ZM | 1 |
| Hu, ZW | 1 |
| Wang, SY | 1 |
| Zhao, B | 1 |
| Stefanovic, AN | 1 |
| Lindhoud, S | 1 |
| Semerdzhiev, SA | 1 |
| Claessens, MM | 1 |
| Subramaniam, V | 1 |
| Coleman, BM | 1 |
| Nisbet, RM | 1 |
| Han, S | 1 |
| Cappai, R | 1 |
| Hatters, DM | 1 |
| Hill, AF | 1 |
| Yeh, HH | 1 |
| Yang, YH | 1 |
| Chen, SH | 1 |
| Janoshazi, A | 1 |
| Sellal, F | 1 |
| Marescaux, C | 1 |
| Danion, JM | 1 |
| Warter, JM | 1 |
| de Barry, J | 1 |
| Junn, E | 1 |
| Taniguchi, H | 1 |
| Jeong, BS | 1 |
| Zhao, X | 1 |
| Ichijo, H | 1 |
| Mouradian, MM | 1 |
| Bora, SS | 1 |
| Radichevich, I | 1 |
| Werner, SC | 1 |
1 trial available for erythrosine and Parkinson Disease
| Article | Year |
|---|---|
Artifactual elevation of PBI from an iodinated dye used to stain medicinal capsules pink.
Topics: Bipolar Disorder; Blood Proteins; Capsules; Carbonates; Chromatography, Paper; Clinical Trials as To | 1969 |
10 other studies available for erythrosine and Parkinson Disease
| Article | Year |
|---|---|
Single-vesicle imaging reveals lipid-selective and stepwise membrane disruption by monomeric α-synuclein.
Topics: alpha-Synuclein; Fluoresceins; Humans; Kinetics; Lipid Bilayers; Membrane Lipids; Membranes; Nerve T | 2020 |
Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteins.
Topics: alpha-Synuclein; Amyloidogenic Proteins; Animals; Autophagy; Biological Transport; Brain; Cells, Cul | 2017 |
Nicotine-Induced Neuroprotection in Rotenone In Vivo and In Vitro Models of Parkinson's Disease: Evidences for the Involvement of the Labile Iron Pool Level as the Underlying Mechanism.
Topics: Analysis of Variance; Animals; Cell Count; Disease Models, Animal; Dopamine; Dopaminergic Neurons; D | 2019 |
Two conformationally distinct α-synuclein oligomers share common epitopes and the ability to impair long-term potentiation.
Topics: Aldehydes; alpha-Synuclein; Animals; Circular Dichroism; Docosahexaenoic Acids; Epitopes; Fatty Acid | 2019 |
[Neuroprotective effects of paeonol in a cell model of Parkinson disease].
Topics: 1-Methyl-4-phenylpyridinium; Acetophenones; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase | 2015 |
Oligomers of Parkinson's Disease-Related α-Synuclein Mutants Have Similar Structures but Distinctive Membrane Permeabilization Properties.
Topics: alpha-Synuclein; Cell Membrane Permeability; Fluoresceins; Humans; Membranes, Artificial; Multiprote | 2015 |
Conformational detection of prion protein with biarsenical labeling and FlAsH fluorescence.
Topics: Alzheimer Disease; Animals; Cysteine; Fluoresceins; Fluorescence; Huntington Disease; Luminescent Me | 2009 |
Simultaneous determination of memantine and amantadine in human plasma as fluorescein derivatives by micellar electrokinetic chromatography with laser-induced fluorescence detection and its clinical application.
Topics: Acetonitriles; Alzheimer Disease; Amantadine; Antiparkinson Agents; Chemical Fractionation; Chromato | 2010 |
Alteration of protein kinase C conformation in red blood cells: a potential marker for Alzheimer's disease but not for Parkinson's disease.
Topics: Age Factors; Aged; Alzheimer Disease; Analysis of Variance; Biomarkers; Enzyme Inhibitors; Erythrocy | 2006 |
Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Blotting, Western; Carrier Proteins; Cell Nucleus; | 2005 |